Carregant...
Playing POLO-like kinase in NRAS mutant melanoma
NRAS-mutant melanomas are extremely aggressive and highly resistant to currently available therapeutic modalities. Hence, new targets and therapeutic strategies for NRAS-driven melanomas are needed. As blocking NRAS directly has not been possible thus far, targeting downstream NRAS effectors, such a...
Guardat en:
| Publicat a: | J Invest Dermatol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4568563/ https://ncbi.nlm.nih.gov/pubmed/26358384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2015.253 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|